Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huoxue Qianyang (HXQY) decoction is a Traditional Chinese Medicine (TCM) herbal formula primarily investigated for its cardioprotective and antihypertensive effects. It is specifically noted for ameliorating cardiac remodeling in obese spontaneously hypertensive models. The therapeutic mechanism is associated with the regulation of endoplasmic reticulum (ER) stress, specifically through the inhibition of the activating transcription factor 6 (ATF6) and C/EBP homologous protein (CHOP) signaling pathways. Additionally, HXQY decoction has shown efficacy in reducing systolic blood pressure, body weight, and improving metabolic parameters such as insulin resistance and lipid profiles (total cholesterol and LDL-C).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on huoxue qianyang decoction.